The ongoing pandemic of Coronavirus disease 2019 (COVID-19) required a firm and prompt effort into the development of an effective vaccine. Reports of adverse reactions are increasing. Lichen planus, and its oral variant, is a condition that has been previously reported associated with vaccines. This is one of the first report of oral lichenplanus(OLP) arising after any COVID-19 vaccine. Here we present two cases of OLP occurred after BNT162b2 mRNA COVID-19 vaccination (Comirnaty, Pfizer, New York, NY, USA; BioNTech, Mainz, Germany).
Oral Lichen Planus arising after BNT162b2 mRNA COVID-19 Vaccine: report of two cases